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Introduction
Cancer is a major public health problem in Iran and 
many other parts of the world. About 14 million new cases 
of cancer and 8.2 million cancer deaths were occurred 
all over the world (Ferlay et al., 2013). According to 
Globocan 2012, the age-standardized incidence rates 
(ASR) of all cancers were 205 and 165 per 100,000 person-
year among male and female, respectively. 57% of new 
cancer cases and 65% of the cancer deaths occurred in the 
less developed regions. Cancer is the third most common 
known cause of death in Iran (Goya, 2007; Naghavi et 
al., 2009). Malignancies of the female reproductive tract 
(uterine corpus, uterine cervix, ovary, vulva, vagina, 
fallopian tube, and placental cancers) are estimated to be 
the third most common group of malignancies in women 
(Ferlay et al., 2013).
Cancer of the uterus is primarily a cancer of the 
developed world with higher incidence rates than those 
of the less developed countries (Sasco, 2001; Ferlay et al., 
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Abstract
 Background: Malignancies of the female reproductive tract are estimated to be the third most common group 
of cancers in women. Objectives: We here aimed to present their epidemiological features in Golestan province 
located in Northeast of Iran. Materials and Methods: Data on primary female reproductive cancers diagnosed 
between 2004-2010 were obtained from Golestan Population-based Cancer Registry (GPCR). CanReg-4 and 
SPSS software were used for data entry and analysis. Age standardized incidence rates (ASR) (per 100,000 
person-years) were calculated using the world standard population. Poisson regression analysis was used to 
compare incidence rates. P-values of less than 0.05 were considered as significant. Results: A total of 6,064 
cancer cases were registered in Golestan females in the GPCR during 2004-2010, of which 652 cases (11%) were 
female reproductive cancers. Cancers of the ovary (ASR=6.03) and cervix (ASR=4.97) were the most common. 
We found significant higher rates in females living in cities than in villages. Our results showed a rapid increase 
in age specific incidence rates of female reproductive cancers at the age of 30 years. Conclusions: We found 
significant higher rates of female reproductive cancers among residents of cities than villages. Differences in 
the prevalence of risk factors including reproductive behavior between the two populations may partly explain 
such diversity. Our results also showed a rapid increase in incidence rates of these cancers in young age females. 
Further studies are warranted to determine risk factors of female reproductive cancers in our population. 
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2013; Binesh et al. 2014). However, developing countries 
have much higher rates of cervical cancer and, worldwide, 
and there are three times as many cases of cervical cancer 
as uterine cancer diagnosed each year (National Cancer 
Intelligence Network, 2008). Cervical cancer is the most 
common malignant disease afflicting women in many 
developing countries (Jemal et al., 2011; Parkin et al., 
2001). It is the most common cause of cancer deaths in 
the South-East Asia Region as well as the African Region. 
Other cancers of the female reproductive tract are the 
eighth (ovary) and thirteenth (uterus) leading causes of 
cancer deaths globally (Mathers et al., 2008).
The first step in controlling the cancer burden in 
each population is to know their status in the population 
and collect information about the incidence, type, and 
location of cancers. In this article, we therefore provide 
an overview of epidemiology of female reproductive 
cancers based on the data available from a population-
based cancer registry in Golestan province located in the 
Northeast of Iran.
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Materials and Methods
Data on primary female reproductive cancers 
diagnosed between 2004-2010 were obtained from 
Golestan Population-based Cancer Registry (GPCR). 
Secondary tumors resulting from the invasion or metastasis 
of other primary cancers were excluded from this report. 
GPCR is an ongoing population-based cancer in Golestan 
province of Iran. It is a voting member of the international 
association of cancer registries (IACR). The process 
of data collection in GPCR was described previously 
(Roshandel et al., 2012). In brief, data on primary cancers 
were registered based on standards of the IACR. Data 
were collected from all public and private diagnostic and 
therapeutic centers (hospitals, pathology laboratories, 
diagnostic radiology clinics and some of the specialist 
physician’s private offices) throughout the Province. 
Information from medical centers and regional registries 
in neighboring provinces were obtained to minimize loss 
of the data and consequent underestimation. Two types of 
questionnaires, the first for out-patient and the second for 
inpatients cases were used. These questionnaires have been 
prepared based on IACR standards. Well-trained registry 
staff regularly visited all centers and collected information 
on cancer cases both actively and passively. Information 
about cancer related deaths was obtained from the death 
registry at the health department of Golestan University 
of medical sciences (GOUMS) and was matched with 
the file of registered cancer patients to identify additional 
unreported cases, which were classified as death certificate 
only cases (DCO). Items collected in GPCR consisted on 
the patient’s demographic characteristics (first name, last 
name, father’s name, sex, age, address and phone number), 
anatomical site of tumor, histology of tumor, method of 
diagnosis and incidence date. To assess the quality of 
data, about 10% of questionnaires were re-checked and 
compared with original documents in patients’ files in 
sources. Cancer cases were classified according to the 
third edition of International Classification of Diseases 
for Oncology (ICD-O-III) (Fritz et al., 2000).
Data was entered into CanReg-4 software, created, and 
published by IACR. Finally, numbers of cases by sex, age 
and primary site as well as crude incidence rates and age 
standardized incidence rates (ASR) (per 1000000 person-
years) were calculated using world standard population. 
Data on Golestan population was obtained from statistics 
office of Deputy of health of Golestan University of 
Medical Sciences. Poisson regression analysis was used 
to compare incidence rates. P-value of less than 0.05 was 
considered as significant.
Results 
A total number of 6064 cancer cases were registered 
in Golestan females in the GPCR during 2004-2010, of 
which, 652 cases (11%) were female reproductive cancers. 
The mean (sd) age of these patients was 48.23 (14.88) 
years. 386 (59.2%) of female reproductive cancer cases 
lived in cites and the remaining 266 patients (40.8%) 
were from villages. Cancers of the ovary (284; 43.6%) 
and cervix (212; 32.5%) were the most common female 
reproductive cancers. Table 1 shows the distribution of 
cancers of the female reproductive organs according to 
patients’ place of residence. The crude incidence rates 
and ASRs of cancers of the female reproductive organs 
are shown in Table 2. We found significant higher rates 
of female reproductive cancers in females lived in cities 
than those of villages (Table 2). Figure 1 showed the age 
specific incidence rates of female reproductive cancers 
in residents of cities and villages of Golestan province. 
We found a rapid increase in age specific incidence rate 
of female reproductive cancers at the age of 30 years 
followed by a slight decrease and then the second increase 
was started at the age of 65 years. 
Table 1. Distribution of Cancers of Female Reproductive 
Organs According Patients’ Place of Residence in 
Golestan Province of Iran, 2004-2010
Organ City Village Total
 Number Percent Number Percent Number
Cervix 131 61.8 81 38.2 212
Uterine 66 56.9 50 43.1 116
Ovary 173 60.9 111 39.1 284
Placenta 6 27.3 16 72.7 22
Others 10 55.6 8 44.4 18
Total 386 59.2 266 40.8 652
Table 2. Crude Rates and age Standardized Incidence 
Rates (ASR) (Per 100000 Persons-Year) of Cancers 
of Female Reproductive Organs According Patients’ 
Place of Residence in Golestan Province of Iran, 2004-
2010
Organ Crude Rate ASR
Cervix City 4.6 6.22 
 Village 2.76 3.77 <0.001
 Total 3.66 4.97
Uterus City 2.32 2.98 
 Village 1.7 2.24 0.049
 Total 2 2.6
Ovary City 6.07 7.51 
 Village 3.78 4.56 <0.001
 Total 4.91 6.03
Placenta City 0.21 0.15 
 Village 0.54 0.47 0.021
 Total 0.38 0.31
Others City 0.35 0.52 
 Village 0.27 0.43 0.079
 Total 0.31 0.48
Total City 13.54 17.39 
 Village 9.05 11.48 <0.001
 Total 11.26 14.39 
Figure 1. Age Specific Incidence Rates (Per 100000 
Persons-Year) of Female Reproductive Cancers in 
Residents of Cities and Villages of Golestan Province 
of Iran During 2004-2010
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Discussion
We aimed to describe the epidemiologic characteristics 
of female reproductive cancers in Golestan province 
located in Northern Iran.
Our results showed significant higher rates of female 
reproductive cancers including cancers of the cervix, 
uterus and ovary in females living in cities than those from 
villages. This may mostly be explained by disparities in 
socioeconomic status (Rohani-Rasaf et al., 2012; Rohani-
Rasaf et al., 2013) as well as differences in life style 
especially reproductive behaviors between residents of 
cities and villages. This issue may be clarified in future 
studies focusing on differences in the prevalence of risk 
factors of female reproductive cancers between the two 
areas.
We found two peaks for age specific incidence rates 
of female reproductive cancers. The first one started at 
the age of 30 years and the second peak one started at the 
age of 65 years. Similar pattern was previously reported 
for breast cancer in this region (Taheri et al., 2012) and 
other parts of Iran (Arab et al., 2014). Increasing the 
rate of these cancers at young ages is an important issue 
suggesting possible changes in the prevalence of risk 
factors in new generations. Further studies are needed 
to clarify different aspects of this point and it should be 
considered for implementation of controlling programs 
for these cancers within the community.
The ASR of cervical cancer in Golestan female was 
4.97 per 100000 persons-year. According to cancer data 
published by IARC, the ASR of cervical cancer in our 
population was relatively similar to the rates reported for 
other parts of Iran (Talaiezadeh et al., 2013) and some 
developed countries including the USA (5.4), UK (6.8) 
and Sweden (6.9) as well as some developing countries 
including Kuwait (4.6) and Turkey (5.4) (Forman et 
al., 2013). High incidence rates of cervical cancer were 
reported from some developing countries including South 
Africa (23.8), Brazil (15.2) and Korea (12.5) (Ferlay et 
al., 2013).
Low incidence rate of cervical cancer in some countries 
may be explained by healthy and protected sexual 
behaviors or implementation of effective controlling 
programs such as screening programs (especially in 
developed countries). Further studies are warranted to 
determine the reasons for these discrepancies between 
different regions of the world.
According to our results, the incidence rate of the 
cancer of the uterus was 2.6 per 100000 persons-year. It 
is considerably low when compared to the rates reported 
for other countries including the USA, UK and Turkey 
(Forman et al., 2013) as well as the overall worldwide 
incidence rate of cancer of the uterus (8.3) (Ferlay et al., 
2013). This low rate of cancer of the uterus in our region 
may be explained by reproductive characteristics including 
parity of our population.
Our results showed that the ASR of cancer of the ovary 
was 6.03 per 100000 persons-year. It was similar to the 
rates reported for other parts of Iran (Talaiezadeh et al., 
2013) and other developing countries including Kuwait 
(5.1), Turkey (6.0) and Korea (5.4). The rate of ovarian 
cancer in our population was low when compared to the 
rates reported from developed countries including the 
USA (9.2) and the UK (12.7) (Forman et al., 2013). These 
geographical differences may be contributed to genetic 
factors of cultural habits and lifestyle practices including 
reproductive behaviors in various regions of the world 
(Lowe et al., 2013).
In conclusion, we found significant higher rates of 
female reproductive cancers among residents of cities 
than villages. Differences in the prevalence of risk 
factors including reproductive behaviors between the 
two populations may partly explain such diversity. Our 
results also showed a rapid increase in incidence rates of 
these cancers in young age females. Further studies are 
warranted to determine risk factors of these cancers in 
our population. 
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